Craft

TaiGen Biopharmaceuticals Holdings

Stock Price

NT$13.9

2024-10-29

Market Capitalization

NT$9.9 B

2024-10-29

Revenue

NT$259.5 M

FY, 2025

TaiGen Biopharmaceuticals Holdings Summary

Company Summary

Overview
TaiGen Biopharmaceuticals Holdings (太景醫藥研發控股股份有限公司) is a company that focuses on the development of therapeutics for diseases such as cancer, infections, and diabetic complications. It is involved in drug discovery, clinical trials, regulatory approval, and global product commercialization, with a pipeline that includes internally developed and in-licensed programs.
Type
Public
Status
Active
Founded
2005
HQ
Taipei, TW | view all locations
Website
https://www.taigenbiotech.com/en
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Taipei, Taipei City HQ

    Taiwan

    7F., No. 138, Xinming Rd., Neihu Dist.

TaiGen Biopharmaceuticals Holdings Financials

Summary Financials

Revenue (FY, 2025)
NT$259.5M
Gross profit (FY, 2025)
NT$242.8M
Net income (FY, 2025)
NT$45.2M
Cash (FY, 2025)
NT$145.1M
EBIT (FY, 2025)
NT$74.0M
Enterprise value
$9.8B

Footer menu